Cargando…
Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) is a devastating disease with high morbidity and mortality. Deleterious remodeling in the pulmonary arterial system leads to irreversible arterial constriction and elevated pulmonary arterial pressures, right heart failure, and eventually death. The difficulty i...
Autores principales: | Redel-Traub, Gabriel, Sampson, Kevin J., Kass, Robert S., Bohnen, Michael S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599705/ https://www.ncbi.nlm.nih.gov/pubmed/36291551 http://dx.doi.org/10.3390/biom12101341 |
Ejemplares similares
-
The Impact of Heterozygous KCNK3 Mutations Associated With Pulmonary Arterial Hypertension on Channel Function and Pharmacological Recovery
por: Bohnen, Michael S., et al.
Publicado: (2017) -
Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension
por: Le Ribeuz, Hélène, et al.
Publicado: (2020) -
Potential of the TRPM7 channel as a novel therapeutic target for pulmonary
arterial hypertension
por: Hiraishi, Keizo, et al.
Publicado: (2022) -
Eag and HERG potassium channels as novel therapeutic targets in cancer
por: Asher, Viren, et al.
Publicado: (2010) -
Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension
por: Satoh, Kimio, et al.
Publicado: (2018)